肾下腹主动脉瘤破裂与症状性未破裂开放修复的当代早远期结果:单中心经验
围术期死亡8.6%、院内死亡15.2%,两组无差异;30天死亡唯一预测因素为输血及并发症,远期死亡预测因素包括年龄、就诊肌酐、附加手术、住院时长及各类并发症。作者认为经验丰富的血管团队开放修复破裂肾下腹主动脉瘤结果可与EVAR媲美。
要点
- 开放修复破裂肾下腹主动脉瘤的院内死亡率为15.2%,与症状性未破裂组无差异。
- 30天死亡的唯一预测因素为输血、主要及次要并发症。
- 远期死亡预测因素包括年龄、就诊肌酐、附加手术、住院时长及术后AKI等。
核心结论
- 经验丰富的血管团队开放修复破裂肾下腹主动脉瘤可获得与EVAR完全可比的良好结果。
- 目前仍远缺乏EVAR优于开放修复治疗破裂肾下腹主动脉瘤的稳健科学证据。
研究设计与样本
- 研究为观察性回顾性设计,遵循STROBE声明。
- 按病变分为破裂组75例与未破裂症状性但CT提示濒临破裂组30例。
- 因事件数少且分析为探索性,仅拟合单变量模型。
主要发现
- 术中、围术期和院内死亡率分别为0.9%、8.6%和15.2%,两组间无差异。
- 30天死亡的唯一预测因素为输血、主要和次要并发症。
- 累计随访455人年,总生存率两组无差异。
- 远期死亡预测因素包括年龄、就诊时肌酐、附加手术、住院时长、任何术中并发症、任何围术期并发症、任何主要并发症及术后急性肾损伤。
临床怎么用
- 在经验丰富的血管团队中,开放修复仍可作为破裂肾下腹主动脉瘤的有效治疗选择。
- 围术期应关注输血需求及并发症发生,以识别30天死亡高风险患者。
- 远期随访应重视年龄、肾功能、附加手术及术后急性肾损伤等预测因素。
局限性
- 研究为单中心观察性回顾性设计,样本量有限。
- 因事件数少且分析为探索性,仅采用单变量模型,未行多变量校正。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Observational studies have shown a reduced short-term mortality and increased long-term survival of EVAR over OR in the treatment of ruptured Infrarenal Abdominal Aortic Aneurysm (IAAA). Until now, none of the RCT has gained the result to demonstrate this superiority. Moreover, contemporary reports about results of OR of rIAAA are poor. METHODS: The study is observational and retrospective according to STROBE statement. The patients, unselected and strictly consecutive, were operated in urgency/emergency between 2007 and 2012. All had a preoperative CT angiography. Patients' characteristics, presentation, intraoperative and postoperative details were analyzed to identify factors that can affect the outcome. Considering the small number of events and the exploratory nature of the analyses, only univariate models were fit. RESULTS: One hundred five patients were treated in urgency/emergency setting because of symptomatic. The patients have been divided into two subgroups, based on lesion findings: 75 patients had ruptured IAAA (group A) and 30 patients had unruptured symptomatic IAAA, with CT findings of impending rupture (group B). Intraoperative, perioperative, and in-hospital mortality was respectively 0.9%, 8.6%, and 15.2%, with no difference between the groups. Unique predictors of 30-day mortality were transfusions, major and minor complications. Cumulative follow-up time was 455 person-years. Overall survival was not different between the groups. Predictors of late mortality were: age, creatinine at presentation, adjunctive procedures, length of in-hospital stay, any intraoperative complications, any perioperative complications, any major complication, and postoperative AKI. CONCLUSIONS: An experienced vascular team can achieve very good results in OR of ruptured IAAA, entirely comparable to EVAR. We are still far from a scientifically robust demonstration of the superiority of EVAR over OR in the treatment of ruptured IAAA.
引用
- Arici V, Bozzani A, Rossi M, et al. Contemporary Early and Long-Term Results of Open Repair for Ruptured and Symptomatic Unruptured Infrarenal AAA. Single Center Experience. Ann Vasc Surg. 2019. PMID: 31648034. doi:10.1016/j.avsg.2019.10.040
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。